Clinical Trials
7 trialsNCT04338399 2025-11-17
BURAN
Adlai Nortye Biopharma Co., Ltd.
Phase 3 Completed
NCT02113878 2024-11-05
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Dana-Farber Cancer Institute
Phase 1 Completed
NCT01816984 2021-10-05
PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
University of Chicago
Phase 1/2 Completed
NCT01737450 2019-06-24
PIK-ORL
Centre Leon Berard
Phase 2 Completed
NCT01852292 2018-07-24
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
Novartis
Phase 2 Terminated
NCT01830504 2016-10-05
BKM120
Hospices Civils de Lyon
Phase 2 Unknown
NCT01527877 2012-10-08
Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck
Yonsei University
Phase 2 Unknown